GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Cronos Group Inc.
Cronos Group is a Canadian cannabis company that has received a major investment from tobacco giant Altria. Its share price reflects the slow progress of federal cannabis legalization in the US and the highly competitive Canadian market.
Share prices of companies in the market segment - Narco farm
Cronos is a Canadian cannabis company with Altria as a major investor. Its business segments include both medical and recreational cannabis. We classify it as part of the Narco Farm sector, and the chart below reflects the dynamics of the entire volatile cannabis industry.
Broad Market Index - GURU.Markets
Cronos Group is a Canadian cannabis production and distribution company with a strategic partnership with tobacco giant Altria. As a component of the GURU.Markets index, it represents the legal cannabis sector. The chart below represents the entire market. See how Cronos shares compare to the overall trend.
Change in the price of a company, segment, and market as a whole per day
CRON - Daily change in the company's share price Cronos Group Inc.
The daily price change of Cronos, a cannabis producer, is a measure of its sensitivity to regulatory news. Change_co reflects the high volatility inherent in this sector. This metric is important for formulas on System.GURU.Markets that analyze companies in the emerging cannabis market.
Daily change in the price of a set of shares in a market segment - Narco farm
Cronos Group Inc. is one of the world's largest cannabis companies. This chart highlights the sector's extreme volatility. Comparing it to biotech investor CRON helps us understand its unique R&D strategy compared to its competitors.
Daily change in the price of a broad market stock, index - GURU.Markets
Cronos is a Canadian cannabis company. The sector is characterized by high volatility due to changing regulations and intense competition. The chart below shows average fluctuations in the cannabis industry, reflecting regulatory risks and investor sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Cronos Group Inc.
Cronos, one of the world's largest cannabis producers, has adapted to challenging market conditions over the past year. Its year-over-year share price performance, shown in the chart, reflects its efforts to achieve profitability and the significant regulatory risks it faces.
Annual dynamics of market capitalization of the market segment - Narco farm
Cronos Group Inc. is a Canadian cannabis company with strong backing from tobacco giant Altria. Its performance is heavily dependent on progress in cannabis legalization in the US and its ability to build strong brands. The chart below shows how these factors influence its volatile performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cronos, like other companies in the cannabis market, lives in a world of regulatory news rather than economic cycles. Its stock price is driven not by GDP, but by legalization moves in the US and Europe. The chart tells a story of high hopes and constant disappointments in a sector still waiting for its moment.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Cronos Group Inc.
Cronos, one of Canada's licensed cannabis companies, has monthly fluctuations that reflect the complex state of the Canadian cannabis market, regulatory changes in the US and globally, and its strategic investments.
Monthly dynamics of market capitalization of the market segment - Narco farm
The cannabis market remains one of the most volatile due to regulatory uncertainty and pricing pressure. The sector's dynamics, reflected in the chart, highlight the rollercoaster of investor sentiment. Amid this challenging environment, companies like Cronos Group are struggling to build sustainable businesses.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Cronos Group, a Canadian cannabis producer, operates in a volatile and evolving market. The company's shares are driven by news of legalization and industry consolidation, rather than by general economic trends. Their performance is highly speculative.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Cronos Group Inc.
The weekly performance of Cronos, a Canadian cannabis producer, reflects the volatility of the entire industry. News of legalization in new countries or states, regulatory changes, and competitors' financial results create constant and sharp price fluctuations.
Weekly dynamics of market capitalization of the market segment - Narco farm
Cronos and the entire cannabis sector are driven by broad news about legalization and regulation. Investor sentiment across the industry is creating strong ripples. The chart clearly shows how the company navigates this highly volatile current.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Cronos shares, like those of the entire cannabis sector, are highly sensitive to overall investor risk appetite. Their movements often amplify broader market movements, particularly the NASDAQ tech index. The chart will show this high correlation with market sentiment.
Market capitalization of the company, segment and market as a whole
CRON - Market capitalization of the company Cronos Group Inc.
Cronos Group's market capitalization is the financial valuation of one of Canada's licensed cannabis producers, backed by tobacco giant Altria. The chart reflects both the initial excitement surrounding legalization and the industry's subsequent challenges. Its dynamics tell the story of the struggle for profitability and the search for a sustainable business model in a complex and competitive market.
CRON - Share of the company's market capitalization Cronos Group Inc. within the market segment - Narco farm
Cronos Group is a Canadian company and one of the world's leaders in cannabis production. Its share of the sector reflects its scale and strategic partnerships, particularly with Altria. The chart shows the company's weight in the global industry, which is growing as legalization and consumer demand increases.
Market capitalization of the market segment - Narco farm
Cronos Group is one of Canada's leading cannabis companies. The chart below shows the total market capitalization of this young and volatile sector. Its dynamics are a story of legalization, regulatory changes, and the search for a sustainable business model, in which Cronos is trying to find its way.
Market capitalization of all companies included in a broad market index - GURU.Markets
The cannabis industry, struggling to find its place on the global stage, is a volatile sector. Cronos Group is a Canadian producer trying to build a global brand. Its market cap, bolstered by investments from a tobacco giant, reflects the high risks and regulatory uncertainty in this market.
Book value capitalization of the company, segment and market as a whole
CRON - Book value capitalization of the company Cronos Group Inc.
Cronos Group's book value is the material foundation for innovation in the cannabis industry. The chart reflects the value of its production facilities, R&D centers conducting research into cannabinoid biosynthesis, and strategic investments. These are physical assets focused on the future of the industry.
CRON - Share of the company's book capitalization Cronos Group Inc. within the market segment - Narco farm
Cronos Group, a Canadian cannabis producer, has significant production assets. Its stake in the sector includes state-of-the-art greenhouses, extraction labs, and research centers. This physical infrastructure forms the foundation for the creation of cannabinoid-based products.
Market segment balance sheet capitalization - Narco farm
Cronos Group is a Canadian cannabis producer. This sector, as the chart shows, is capital-intensive. Cronos uses a hybrid model. It owns production facilities but also relies on an asset-light approach through R&D and brand building.
Book value of all companies included in the broad market index - GURU.Markets
Cronos Group is a Canadian cannabis company. Its net worth comes from its cultivation and processing facilities, as well as significant cash from Altria Group investments, which fund its research and international expansion.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Cronos Group Inc.
Cronos Group is a cannabis company. Its market capitalization is below its book value, which is largely comprised of Altria's cash. This reflects investor pessimism about the growth and profitability prospects of the entire cannabis industry.
Market to book capitalization ratio in a market segment - Narco farm
Cronos Group is a Canadian company operating in the cannabis industry. Its valuation is heavily dependent on regulatory changes and its ability to build strong brands. This chart shows how investors view its prospects and current assets compared to other players in this volatile market.
Market to book capitalization ratio for the market as a whole
Cronos Group is a Canadian cannabis company that has received a major investment from Altria. Compared to average market valuations, as shown in this chart, its valuation is highly volatile, reflecting both the growth potential of the legal cannabis market and regulatory uncertainty and intense competition.
Debts of the company, segment and market as a whole
CRON - Company debts Cronos Group Inc.
Cronos Group is a Canadian company engaged in the production and sale of cannabinoids. Despite legalization, this is still an emerging industry with high capital expenditures on cultivation, processing, and research. This chart illustrates how the company is using debt to build brands, expand production capacity, and develop new markets.
Market segment debts - Narco farm
Cronos Group is a Canadian company operating in the cannabis industry. The sector is facing challenges from oversupply and slow growth in legal markets. Many companies are suffering losses. Managing cash and debt is critical to survival. This chart shows Cronos' financial position in this challenging market environment.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Cronos Group Inc.
Cronos Group is a company operating in the cannabis industry. This chart shows its reliance on debt financing in a volatile and highly competitive market. Debt management is critical, as regulatory changes and price wars could dramatically impact the company's profitability and ability to meet its financial obligations to creditors.
Market segment debt to market segment book capitalization - Narco farm
Cronos Group is a Canadian company operating in the cannabis industry. This young and volatile sector faces regulatory challenges and intense competition. This chart shows the overall debt load in the industry, allowing one to assess how Cronos manages its finances and whether it is leveraging debt for expansion compared to other cannabis producers.
Debt to book value of all companies in the market
Cronos Group Inc. is a company operating in the cannabis industry. The sector is still in its infancy and faces regulatory and financial challenges. The chart shows general borrowing terms, but Cronos' access to traditional debt may be limited, forcing it to seek alternative ways to finance its growth and operations.
P/E of the company, segment and market as a whole
P/E - Cronos Group Inc.
This chart for Cronos Group, a Canadian cannabis producer, reflects the challenges of the fledgling industry. The company's P/E, if positive, is likely to be volatile. It illustrates the struggle for profitability amid intense competition, oversupply, and complex regulations that are preventing the sector from realizing its potential.
P/E of the market segment - Narco farm
Cronos Group is a Canadian company specializing in the production and sale of cannabinoids for both medical and recreational use. The company has attracted significant investment from tobacco giant Altria. This chart shows the average valuation for the sector, helping to understand the market's perception of the prospects for legalization and profitability in this nascent industry.
P/E of the market as a whole
Cronos Group is a Canadian company engaged in the production and sale of cannabis. The industry has faced challenges from oversupply and slow legalization. Cronos's valuation depends less on general economic trends than on industry-specific factors: regulatory changes (particularly in the US), price competition, and the ability to achieve profitability.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Cronos Group Inc.
Cronos Group is a Canadian company engaged in the production and sale of cannabinoids. Its future depends on legalization, the regulatory environment, and its ability to create branded products. This chart shows how investors assess the long-term prospects of the cannabis market and Cronos's ability to carve out a profitable niche within it, despite the current uncertainty.
Future (projected) P/E of the market segment - Narco farm
Cronos Group is a Canadian company engaged in the production and sale of cannabinoids. Its future depends on the legalization and development of the cannabis market. This chart shows general profitability expectations for related sectors. CRON's position relative to the average reflects how the market views this particular player's prospects in an environment of intense competition and regulatory uncertainty.
Future (projected) P/E of the market as a whole
Cronos Group is a Canadian company operating in the cannabis industry. This sector is highly dependent on regulatory changes and investor sentiment. This chart shows overall risk appetite. The valuation of companies in emerging and volatile industries, like Cronos, is particularly sensitive to overall market optimism or pessimism.
Profit of the company, segment and market as a whole
Company profit Cronos Group Inc.
Cronos Group is a Canadian company engaged in the production and sale of cannabinoids for medical and recreational use. This chart shows its financial performance in a highly volatile and evolving market. Profit is dependent on sales volume, product prices, and operational efficiency.
Profit of companies in the market segment - Narco farm
Cronos Group is a Canadian company engaged in the production and sale of cannabinoids. Its development depends on legalization, regulation, and changing consumer attitudes toward the product. This chart shows the collective profitability of this young industry. It helps assess whether the sector is in its infancy, facing regulatory barriers, or has already achieved stable profitability.
Overall market profit
Cronos Group, a player in the cannabis market, operates in a young and volatile industry. Its success depends on legalization, regulation, and consumer spending. When the economy is stable, as indirectly reflected by the profit growth in this chart, consumers have more disposable income, and the company has more opportunities to invest in the production and marketing of its products.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Cronos Group Inc.
Cronos Group is a Canadian company engaged in the production and sale of cannabis for medical and recreational use. Its profitability depends on legalization, market growth, and the ability to build strong brands. This chart displays analyst expectations for the future development of the cannabis industry and Cronos's place in it, including its partnership with Altria.
Future (predicted) profit of companies in the market segment - Narco farm
Cronos Group is a Canadian company engaged in the production and sale of cannabis for medical and recreational use. Its financial performance depends on legalization, competition, and the ability to build strong brands. This chart shows overall profitability forecasts for the entire sector, allowing investors to assess how Cronos' strategy stacks up against the backdrop of a volatile and evolving industry.
Future (predicted) profit of the market as a whole
Cronos Group is a Canadian cannabis producer. The industry is still in its infancy and is highly dependent on regulatory changes and consumer preferences. The overall economic situation, reflected in this chart, has less of an impact on it than mature sectors, but it can influence consumer discretionary spending on these products.
P/S of the company, segment and market as a whole
P/S - Cronos Group Inc.
Cronos Group is a Canadian cannabis producer. This chart shows how much the company's valuation depends on regulatory changes and investor sentiment surrounding this fledgling industry. Fluctuations in this valuation reflect not so much current sales as hopes for legalization in key markets, primarily the US, and future demand growth.
P/S market segment - Narco farm
Cronos Group is a Canadian company engaged in the production and sale of cannabinoids for medical and recreational use. Revenue is generated from product sales in legal markets. This chart reflects the average valuation for companies in the cannabis sector, helping to understand how investors view Cronos' brand, products, and growth strategy in this emerging market.
P/S of the market as a whole
Cronos Group is a Canadian company engaged in the production and sale of cannabis for medical and recreational purposes. Its revenue depends on legalization, consumer demand, and competition in this emerging market. This chart displays overall revenue estimates, providing insight into how the market views the prospects and risks of the cannabis industry compared to more traditional sectors.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Cronos Group Inc.
Cronos Group is a Canadian company engaged in the production and sale of cannabis for medical and recreational purposes. Its future revenue depends on legalization, consumer demand, and competition. This chart shows how the market views the company's sales growth prospects, factoring in expectations for expansion into new markets and the launch of innovative products.
Future (projected) P/S of the market segment - Narco farm
Cronos Group is a Canadian cannabis company that has received significant investment from tobacco giant Altria. The company's valuation reflects investors' expectations regarding its ability to create innovative products (such as those using fermentation), build global brands, and capitalize on the potential federal legalization of cannabis in the United States.
Future (projected) P/S of the market as a whole
Cronos Group Inc. is a Canadian company operating in the cannabis market. Its growth depends on legalization and the development of this new consumer market. This chart shows general expectations, and Cronos represents one of the youngest and most volatile industries.
Sales of the company, segment and market as a whole
Company sales Cronos Group Inc.
Cronos Group is a Canadian company engaged in the production and sale of cannabis. This chart shows its revenue, which is generated from the sale of recreational and medical products, including dried flower, oils, and vapes. Sales dynamics depend on the regulatory environment, consumer demand, and the ability to introduce new brands to the market.
Sales of companies in the market segment - Narco farm
Cronos Group (CRON) is a Canadian company engaged in the production and sale of cannabis for medical and recreational purposes. It invests in research and development, creating products based on rare cannabinoids. This figure reflects the size of the legal cannabis market, where Cronos aims to occupy the premium segment through innovation and strong brands.
Overall market sales
Cronos Group is a Canadian company engaged in the production and sale of cannabis for medical and recreational purposes. The cannabis market, being a consumer market, is sensitive to the overall economic situation. This graph shows the dynamics of disposable income: during periods of growth, people are more willing to spend money on non-essential items, including Cronos products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Cronos Group Inc.
Cronos Group is a Canadian company engaged in the production and sale of cannabinoids. Its revenue depends on the legalization of cannabis in new markets, consumer demand, and the development of branded products. This chart shows analysts' sales growth expectations, which serve as a barometer for the development of the global legal cannabis market and the company's strategy.
Future (projected) sales of companies in the market segment - Narco farm
Cronos Group is a Canadian company engaged in the production and sale of cannabis. The forecast in this chart details expected revenue, likely segmented by geographic markets (Canada, Israel) or product categories. This shows which markets and products the company is focusing on for future growth in a competitive industry.
Future (projected) sales of the market as a whole
Cronos Group is a Canadian company operating in the cannabis industry. Its success depends on regulatory changes, consumer preferences, and the ability to achieve profitability. This chart, reflecting overall consumer spending, helps assess demand for recreational products, which include cannabis products, in legalized markets.
Marginality of the company, segment and market as a whole
Company marginality Cronos Group Inc.
Cronos Group is a Canadian company engaged in the production and sale of cannabis for medical and recreational use. Profitability in this young industry depends on production scale, regulatory changes, and the ability to build strong brands. The chart shows how Cronos is navigating intense competition and pricing pressure while striving for sustainable profitability.
Market segment marginality - Narco farm
Cronos Group is a Canadian company engaged in the production and sale of cannabis for medical and recreational use. This chart shows its path to operational profitability in a complex and highly regulated industry. Success depends on the strength of its brands, production efficiency, and the ability to adapt to changing regulations.
Market marginality as a whole
Cronos Group, a cannabis producer, operates in a young and volatile industry. This graph of overall profitability by economy allows investors to compare the sector's profitability with established markets. It clearly demonstrates how cannabis producers' margins are dependent on regulatory changes and competition, rather than general economic cycles.
Employees in the company, segment and market as a whole
Number of employees in the company Cronos Group Inc.
Cronos Group is a Canadian company operating in the cannabis industry. Its headcount dynamics reflect strategic shifts in the business. Growth may be due to expansion of production capacity or entry into new markets, while layoffs may indicate optimization and a focus on higher-margin products.
Share of the company's employees Cronos Group Inc. within the market segment - Narco farm
Cronos Group is a global cannabinoid company engaged in research, production, and marketing. In this young and rapidly growing industry, the headcount reflects the operational scale—from cultivation to scientific development. This chart shows the human resources Cronos is devoting to developing its brand and products in the global cannabis market.
Number of employees in the market segment - Narco farm
Cronos Group is a Canadian cannabis producer with global ambitions. This chart, which reflects employment in the legal cannabis sector, shows the stages of the industry's development: from rapid growth to consolidation. For Cronos, this data is important for assessing the market's scale, the level of competition, and the availability of agronomists and processing specialists needed for production.
Number of employees in the market as a whole
Cronos Group is a global cannabinoid company. Its workforce, from cultivation to research, is shaped by changing regulations and consumer demand. Overall economic health, as depicted in this graph, influences discretionary spending, which fuels this burgeoning consumer goods sector.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Cronos Group Inc. (CRON)
Cronos Group is a Canadian company engaged in the production and sale of cannabis. The business combines agriculture and biotechnology (producing cannabinoids through fermentation). This chart shows how the market values not only current sales but also the company's technological potential, which could generate high value with lower costs.
Market capitalization per employee (in thousands of dollars) in the market segment - Narco farm
Cronos Group is a Canadian cannabis producer. In this young and volatile industry, PE (market capitalization per employee) reflects not only current operating performance but also market expectations regarding growth, brands, and legalization. This chart helps assess the company's competitive position in the future market.
Market capitalization per employee (in thousands of dollars) for the overall market
Cronos Group is a Canadian company engaged in the production and sale of cannabinoids. This chart shows the market valuation of one player in a relatively new and volatile industry. It reflects not only current operations but also the value of brands, licenses, and scientific developments in cannabis breeding and production.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Cronos Group Inc. (CRON)
Cronos Group is a Canadian cannabis producer. The industry is characterized by high competition, regulatory complexities, and pricing pressure. This chart is a brutal indicator of performance. It shows how successfully the company manages cultivation, processing, and logistics while striving to achieve profitability in a very challenging market environment.
Profit per employee (in thousands of dollars) in the market segment - Narco farm
Cronos Group is a Canadian company engaged in the production and sale of cannabis. The industry is still in its infancy, facing regulatory challenges and price competition. This chart shows how effectively Cronos manages its cultivation and processing facilities in a challenging market environment.
Profit per employee (in thousands of dollars) for the market as a whole
Cronos Group is a Canadian company engaged in the production and sale of cannabis for medical and recreational purposes. This indicator helps assess how effectively a company in a new but operationally complex industry generates profits, taking into account personnel costs at all stages—from agronomists to lawyers.
Sales to employees of the company, segment and market as a whole
Sales per company employee Cronos Group Inc. (CRON)
Cronos Group is a Canadian company engaged in the production and distribution of cannabis. Revenue per employee in this growing industry reflects the efficiency of cultivation, processing, and distribution. This chart shows how the company is scaling its operations and building brands in legal markets while facing regulatory and pricing challenges.
Sales per employee in the market segment - Narco farm
Cronos Group (CRON) is a Canadian company engaged in the production and distribution of cannabis for medical and recreational use. This metric reflects the average revenue per employee in the segment. It helps assess how effectively Cronos manages its production and distribution operations compared to other market players.
Sales per employee for the market as a whole
Cronos Group (CRON) is a Canadian company engaged in the production and sale of cannabis. This sector is characterized by high competition, regulatory complexities, and pricing pressure. This metric measures Cronos' operational efficiency—from cultivation to processing and distribution. It demonstrates how successfully the company manages its production costs and personnel to generate revenue in a volatile market.
Short shares by company, segment and market as a whole
Shares shorted by company Cronos Group Inc. (CRON)
Cronos Group (CRON) is a Canadian cannabis company that has received a major investment from tobacco giant Altria. Despite this, the legal cannabis sector suffers from oversupply and regulatory barriers. This chart measures skepticism. The high number of short positions reflects market disillusionment with the sector and doubts about Cronos's ability to achieve profitability. (347)
Shares shorted by market segment - Narco farm
Cronos is a Canadian cannabis producer that has received significant investment from Altria (Marlboro). This chart shows the overall sentiment in the sector. It reflects investor pessimism regarding the entire cannabis industry, which is suffering from losses, oversupply, and slow legalization.
Shares shorted by the overall market
Cronos Group is a player in the cannabis market. The sector is already plagued by regulatory issues and a lack of profitability. When this overall pessimism rises, investors completely lose their appetite for risk. They sell off unprofitable, speculative sectors en masse, and cannabis companies like CRON find themselves at the epicenter of this sell-off.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Cronos Group Inc. (CRON)
Cronos Group (CRON) is a Canadian licensed cannabis producer. The company is backed by Altria (the maker of Marlboro). Their business is betting on legalization and branded products. This chart measures hype. It shows "overbought" (above 70) on news of legalization in the US or "oversold" (below 30) amid oversupply and price wars in Canada.
RSI 14 Market Segment - Narco farm
Cronos Group (CRON) is a Canadian licensed cannabis producer that has received a major investment from tobacco giant Altria. This chart measures the collective sentiment in the cannabis sector. It shows when the entire industry is overheated by legalization news or oversold due to regulatory hurdles, which is the primary context for CRON.
RSI 14 for the overall market
Cronos Group (CRON), a cannabis producer. This chart is an indicator of risk appetite. During periods of euphoria, investors are willing to invest in growth stories, ignoring losses and regulatory risks. In moments of panic, capital flees speculative, unprofitable industries, and the cash spigot for cannabis companies is shut off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast CRON (Cronos Group Inc.)
Cronos Group is a Canadian company focused on cannabis production and research. The company has focused on R&D and the production of cannabinoids through fermentation. This chart shows the average price target analysts are predicting for the company, assessing its scientific strategy in a volatile industry.
The difference between the consensus estimate and the actual stock price CRON (Cronos Group Inc.)
Cronos Group is a Canadian cannabis (marijuana) producer. Their business involves growing, processing, and selling recreational and medical marijuana. Their main asset is a major investment from Altria (the maker of Marlboro). This chart shows how analysts assess their chances of survival in a crowded industry and their hopes for legalization in the US.
Analyst consensus forecast for stock prices by market segment - Narco farm
Cronos Group is a Canadian cannabis producer that has received billions in investment from Altria (Marlboro). The company is trying to build a global brand in a volatile market. This chart shows analysts' overall expectations for the cannabis sector, reflecting whether experts believe in legalization and the industry's profitability.
Analysts' consensus forecast for the overall market share price
Cronos Group is a Canadian company engaged in the production and sale of cannabis. The company is backed by tobacco giant Altria. This chart shows overall risk appetite. For Cronos, which operates in the volatile cannabis sector dependent on legalization, overall market optimism is important, but regulatory news in the US carries far more weight than general sentiment.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Cronos Group Inc.
Cronos Group is one of Canada's largest licensed cannabis producers, having received a massive investment from tobacco giant Altria (Marlboro). Their business encompasses cultivation, R&D (synthetic cannabinoids), and international sales. This chart is a barometer of the volatile cannabis industry, reflecting their massive cash hoard, the price war in Canada, and speculative hopes for legalization in the US.
AKIMA Market Segment Index - Narco farm
Cronos (CRON) is a Canadian cannabis giant (L.P.) that (unlike Tilray) has focused on R&D and innovation (laboratory cannabinoid cultivation), having received a massive investment from tobacco giant Altria (MO). This composite metric evaluates companies. The chart shows the sector average. This is a benchmark: how does this R&D-focused model (CRON) differentiate it from the average competitor?
The AKIM Index for the overall market
Cronos Group is a Canadian cannabis producer focused on innovation and brand building (Spinach). It has a partnership with tobacco giant Altria. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this volatile story in the nascent sector compares to overall economic trends and regulatory expectations.